2005
DOI: 10.1007/s00432-005-0009-0
|View full text |Cite
|
Sign up to set email alerts
|

Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance

Abstract: Comparing with HE, RT-PCR can make more accurate assessment of metastatic status in LNs, which is helpful for screening the patients in whom the early subclinical metastasis exists and disclosing the intrinsic regulation of malignant metastasis. The presence of DTCs in LNs is an independent factor for prognosis. Molecular detection of DTCs in LNs is a supplement for current tumor staging in lung carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
12
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 19 publications
0
12
0
Order By: Relevance
“…However, even in early stages, the 5-year survival rate of N0 patients remains at only 60-70% after complete resection of the primary tumor (7,17). This suggests that tumor cell dissemination occurs early and occult micrometastases or single disseminated tumor cells (DTC), which are not discovered by conventional histopathologic methods, may be present in the lymph nodes at the time of surgery (6,16,18,22,26). Detection of these cells might potentially improve clinical lymph node staging and help to identify patients who could benefit from adjuvant or neoadjuvant therapy.…”
Section: Introductionmentioning
confidence: 98%
“…However, even in early stages, the 5-year survival rate of N0 patients remains at only 60-70% after complete resection of the primary tumor (7,17). This suggests that tumor cell dissemination occurs early and occult micrometastases or single disseminated tumor cells (DTC), which are not discovered by conventional histopathologic methods, may be present in the lymph nodes at the time of surgery (6,16,18,22,26). Detection of these cells might potentially improve clinical lymph node staging and help to identify patients who could benefit from adjuvant or neoadjuvant therapy.…”
Section: Introductionmentioning
confidence: 98%
“…As a molecular biology-based technique, it has been shown to be useful in detecting lymph node metastases. This method shows a higher sensitivity for revealing minor tumour deposits in lymph nodes compared to conventional histopathology [15][16][17]. However, this method is not yet used in routine clinical practice, due to its complexity and time-consuming nature.…”
Section: Introductionmentioning
confidence: 99%
“…Some molecular examinations used for the assessment of lymph node status have shown higher positivity rates when compared to routine HE staining as well as immunohistochemistry. Nowadays lymph node metastases are diagnosed more and more often by molecular assays and immunohistochemistry [17][18][19][20][21][22][23][24][25]. The data of these studies may help to find more sensitive methods for the early detection of cell dissemination and may refine risk groups that might benefit from more extensive surgery or adjuvant therapy.…”
Section: Introductionmentioning
confidence: 99%